291 related articles for article (PubMed ID: 33498410)
1. Hepatokines as a Molecular Transducer of Exercise.
Seo DY; Park SH; Marquez J; Kwak HB; Kim TN; Bae JH; Koh JH; Han J
J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33498410
[TBL] [Abstract][Full Text] [Related]
2. Implication of hepatokines in metabolic disorders and cardiovascular diseases.
Jung TW; Yoo HJ; Choi KM
BBA Clin; 2016 Jun; 5():108-13. PubMed ID: 27051596
[TBL] [Abstract][Full Text] [Related]
3. Role of exercise-induced hepatokines in metabolic disorders.
Ennequin G; Sirvent P; Whitham M
Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E11-E24. PubMed ID: 30964704
[TBL] [Abstract][Full Text] [Related]
4. Hepatokines and non-alcoholic fatty liver disease.
Lebensztejn DM; Flisiak-Jackiewicz M; Białokoz-Kalinowska I; Bobrus-Chociej A; Kowalska I
Acta Biochim Pol; 2016; 63(3):459-67. PubMed ID: 27262842
[TBL] [Abstract][Full Text] [Related]
5. Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.
Kim TH; Hong DG; Yang YM
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944728
[TBL] [Abstract][Full Text] [Related]
6. Hepatokines-a novel group of exercise factors.
Weigert C; Hoene M; Plomgaard P
Pflugers Arch; 2019 Mar; 471(3):383-396. PubMed ID: 30338347
[TBL] [Abstract][Full Text] [Related]
7. Role of Hepatokines in Non-alcoholic Fatty Liver Disease.
Ke Y; Xu C; Lin J; Li Y
J Transl Int Med; 2019 Dec; 7(4):143-148. PubMed ID: 32010600
[TBL] [Abstract][Full Text] [Related]
8. Interaction between hepatokines and metabolic diseases.
Liang JQ; Liu C; Zhang WX; Chen SY
Yi Chuan; 2022 Oct; 44(10):853-866. PubMed ID: 36384723
[TBL] [Abstract][Full Text] [Related]
9. Hepatokines as a Link between Obesity and Cardiovascular Diseases.
Yoo HJ; Choi KM
Diabetes Metab J; 2015 Feb; 39(1):10-5. PubMed ID: 25729707
[TBL] [Abstract][Full Text] [Related]
10. Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes.
Hansen JS; Pedersen BK; Xu G; Lehmann R; Weigert C; Plomgaard P
J Clin Endocrinol Metab; 2016 Jul; 101(7):2816-25. PubMed ID: 27163358
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.
Panera N; Della Corte C; Crudele A; Stronati L; Nobili V; Alisi A
Expert Rev Gastroenterol Hepatol; 2016; 10(3):393-403. PubMed ID: 26654761
[TBL] [Abstract][Full Text] [Related]
12. The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans.
Peter A; Kovarova M; Staiger H; Machann J; Schick F; Königsrainer A; Königsrainer I; Schleicher E; Fritsche A; Häring HU; Stefan N
Am J Physiol Endocrinol Metab; 2018 Mar; 314(3):E266-E273. PubMed ID: 29138227
[TBL] [Abstract][Full Text] [Related]
13. Hepatokines: unlocking the multi-organ network in metabolic diseases.
Iroz A; Couty JP; Postic C
Diabetologia; 2015 Aug; 58(8):1699-703. PubMed ID: 26032022
[TBL] [Abstract][Full Text] [Related]
14. Effect of exercise intensity on circulating hepatokine concentrations in healthy men.
Willis SA; Sargeant JA; Thackray AE; Yates T; Stensel DJ; Aithal GP; King JA
Appl Physiol Nutr Metab; 2019 Oct; 44(10):1065-1072. PubMed ID: 31453723
[TBL] [Abstract][Full Text] [Related]
15. The implication of hepatokines in metabolic syndrome.
Esfahani M; Baranchi M; Goodarzi MT
Diabetes Metab Syndr; 2019; 13(4):2477-2480. PubMed ID: 31405664
[TBL] [Abstract][Full Text] [Related]
16. The Role of Organokines in Obesity and Type 2 Diabetes and Their Functions as Molecular Transducers of Nutrition and Exercise.
Lim JY; Kim E
Metabolites; 2023 Aug; 13(9):. PubMed ID: 37755259
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Liver Fat to Weight Loss-Induced Changes in Serum Hepatokines: A Randomized Controlled Trial.
Telgenkamp I; Kusters YHAM; Schalkwijk CG; Houben AJHM; Kooi ME; Lindeboom L; Bons JAP; Schaper NC; Joris PJ; Plat J; Mensink RP; Stehouwer CDA; Brouwers MCGJ
J Clin Endocrinol Metab; 2019 Jul; 104(7):2719-2727. PubMed ID: 30753672
[TBL] [Abstract][Full Text] [Related]
18. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines.
Berezin AA; Obradovic Z; Berezina TA; Boxhammer E; Lichtenauer M; Berezin AE
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36830074
[TBL] [Abstract][Full Text] [Related]
20. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.
Meex RCR; Watt MJ
Nat Rev Endocrinol; 2017 Sep; 13(9):509-520. PubMed ID: 28621339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
